Skip to content

AIRE RESEARCH PROTOCOL: OPERATIONAL EVALUATION OF THE ROUTINE PULSE OXYMETER IMPLEMENTATION INTO THE INTEGRATED MANAGEMENT OF CHILDHOOD ILLNESS (PAPER AND ELECTRONIC) AT PRIMARY HEALTH CARE LEVEL IN WEST AFRICA

AIRE RESEARCH PROTOCOL: «EVALUATING THE OPERATIONAL IMPLEMENTATION OF DECENTRALIZED PULSE OXYMETER IN CHILDREN»

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202206525204526
Enrollment
40000
Registered
2022-06-15
Start date
2021-01-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory and non respiratory Paediatrics

Interventions

Use of pulse oxymeter
Follow up of all severe cases included in AIRE research
Use of Pulse Oxymeter integrated into IMCI consultation

Sponsors

ALIMA NGO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The PO will be used among the following eligible children according to the IMCI classification and depending on age and signs: • 0-59 days: All sick children. • 2-59 months, with cough and breathing difficulties: All sick children (green, yellow or red) • 2-59 months, without cough and breathing difficulties: those classified as moderate (yellow) or severe (red). All neonates (0 to 59 days) and children (2 to 59 months) attending IMCI consultation in research sites of the AIRE project will be screened for PO use eligibility criteria detailed above by the health care professional working at the PHCs. Those eligible for whom at least one caregiver has given consent will be enrolled over the recruitment period

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The study primary endpoint is the added-value of the use of pulse oxymeter in the identification of severe case, respiratory and non respiratory, at PHC level, among all children attended to IMCI consultation in the 4 countries;Description of how the AIRE project works, for who, in which specific contexts and why, using a realist evaluation;Level of acceptability of the innovation (POs) introduced by the project among health workers and children’s caregivers;Description of all AIRE sites introducing PO over the study period: health infrastructures, health care staff, frequency of PO use, and IMCI outpatient characteristics

Secondary

MeasureTime frame
State how the implementation of the AIRE project is organized, what are its challenges, what are the factors that influence it (including e-IMCI vs paper-IMCI);Pathways of care after hospital referral to describe the cascade of care: hospitalizations achieved among severe cases at PHC and delay, drop-out after referral and causes of non-referral, return to care;Patterns of care at hospital: PO use and SpO2 measurement at entry, coverage of oxygen therapy, injectable antibiotics, ACTS, and other specific treatments… (in %, delays, volume, and duration), hospital length, and outcome at hospital discharge;Direct and indirect of both medical and non-medical costs (costs of consultations, medicines, medical equipment, examination and care, staff costs, PO deployment, transport to health centers and hospitals, childcare, accommodation), including loss of income for people accompanying children;Short-term health outcomes at 14 days in terms of vital status and care (died, alive and cured, alive still in care, alive but return to care, lost-to-follow-up), whether they were hospitalized or not and dates of death if any;Description of the implementation fidelity, meaning to which extent the final implementation is in line with the planned AIRE project activities (explore if the activities planned by the project have actually been implemented, and as often and as long as initially planned

Countries

Burkina Faso, Guinea, Mali, Niger

Contacts

Public ContactMarine VIGNON

Project Manager ALIMA

marine.vignon@alima.ngo00221778554159

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026